Immunosenescent characteristics of T cells in young patients following haploidentical haematopoietic stem cell transplantation from parental donors

被引:9
|
作者
Lee, Ga Hye [1 ,2 ]
Hong, Kyung Taek [3 ,4 ]
Choi, Jung Yoon [3 ,4 ]
Shin, Hee Young [3 ,4 ]
Lee, Won-Woo [1 ,4 ,5 ,6 ,7 ,8 ]
Kang, Hyoung Jin [3 ,4 ]
机构
[1] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Plus Biomed Sci Project BK21, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea
[4] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
[5] Seoul Natl Univ, Dept Microbiol & Immunol, Coll Med, Seoul, South Korea
[6] Seoul Natl Univ, Ischem Hypox Dis Inst, Coll Med, Seoul, South Korea
[7] Seoul Natl Univ, Inst Infect Dis, Coll Med, Seoul, South Korea
[8] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
CD28(-) T cells; HaploSCT; immune monitoring; immunosenescence; telomere length; IMMUNE RECONSTITUTION; TELOMERE LENGTH; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; REPLICATIVE SENESCENCE; SIGNALING PATHWAYS; HODGKIN LYMPHOMA; CD8(+) CD28(-); BONE-MARROW; MEMORY; BLOOD;
D O I
10.1002/cti2.1124
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives Paediatric and adolescent patients in need of allogeneic haematopoietic stem cell transplantation (HSCT) generally receive stem cells from older, unrelated or parental donors when a sibling donor is not available. Despite encouraging clinical outcomes, it has been suggested that immune reconstitution accompanied by increased replicative stress and a large difference between donor and recipient age may worsen immunosenescence in paediatric recipients. Methods In this study, paired samples were collected at the same time from donors and recipients of haploidentical haematopoietic stem cell transplantation (HaploSCT). We then conducted flow cytometry-based phenotypic and functional analyses and telomere length (TL) measurements of 21 paired T-cell sets from parental donors and children who received T-cell-replete HaploSCT with post-transplant cyclophosphamide (PTCy). Results Senescent T cells, CD28(-) or CD57(+) cells, were significantly expanded in patients. Further, not only CD4(+)CD28(-) T cells, but also CD4(+)CD28(+) T cells showed reduced cytokine production capacity and impaired polyfunctionality compared with parental donors, whereas their TCR-mediated proliferation capacity was comparable. Of note, the TL in patient T cells was preserved, or even slightly longer, in senescent T cells compared with donor cells. Regression analysis showed that senescent features of CD4(+) and CD8(+) T cells in patients were influenced by donor age and the frequency of CD28(-) cells, respectively. Conclusion Our data suggest that in paediatric HaploSCT, premature immunosenescent changes occur in T cells from parental donors, and therefore, long-term immune monitoring should be conducted.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches
    Chidgey, Ann P.
    Seach, Natalie
    Dudakov, Jarrod
    Hammett, Maree V.
    Boyd, Richard L.
    SEMINARS IN IMMUNOPATHOLOGY, 2008, 30 (04) : 457 - 477
  • [42] Feasible Outcomes of T Cell-Replete Haploidentical Stem Cell Transplantation with Reduced-Intensity Conditioning in Patients with Myelodysplastic Syndrome
    Shin, Seung-Hwan
    Kim, Jung-Ho
    Jeon, Young-Woo
    Yoon, Jae-Ho
    Yahng, Seung-Ah
    Lee, Sung-Eun
    Choi, Yun-Suk
    Kim, Dae-Young
    Lee, Jung-Hee
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Lee, Jong-Wook
    Lee, Kyoo-Hyung
    Min, Woo-Sung
    Kim, Yoo-Jin
    Lee, Je-Hwan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : 342 - 349
  • [43] Second malignancies after autologous haematopoietic stem cell transplantation following modified BEAM conditioning regimen in patients with Hodgkin lymphoma - characteristics and risk factor analysis
    Czyz, Anna
    Lojko-Dankowska, Anna
    Matuszak, Magdalena
    Dytfeld, Dominik
    Kazmierczak, Maciej
    Komarnicki, Mieczyslaw
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (02): : 200 - 204
  • [44] T cell replete-haploidentical second hematopoietic stem cell transplantation for primary graft failure in pediatric patients with hematologic malignancies
    Mochizuki, Kazuhiro
    Sano, Hideki
    Akaihata, Mitsuko
    Kobayashi, Shogo
    Waragai, Tomoko
    Ohara, Yoshihiro
    Takahashi, Nobuhisa
    Ito, Masaki
    Ikeda, Kazuhiko
    Ohto, Hitoshi
    Kikuta, Atsushi
    PEDIATRIC TRANSPLANTATION, 2017, 21 (07)
  • [45] Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis
    O'Donnell, P. V.
    Eapen, M.
    Horowitz, M. M.
    Logan, B. R.
    DiGilio, A.
    Brunstein, C.
    Fuchs, E. J.
    Flowers, M. E. D.
    Salit, R.
    Raj, K.
    Pagliuca, A.
    Bradstock, K.
    Granata, A.
    Castagna, L.
    Furst, S.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 (12) : 1599 - 1601
  • [46] TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience
    Kenkre, Vaishalee P.
    Bradley, Kristin
    Milton, Arissa
    Burkholder, Joseph K.
    Grindle, Kreg
    McMannes, Jan
    Kim, KyungMann
    Callander, Natalie
    Juckett, Mark
    Longo, Walter
    Hematti, Peiman
    LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1875 - 1879
  • [47] Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia
    Zheng, Wenshuai
    Wu, Yamei
    Guan, Lixun
    Cheng, Longcan
    Hu, Yalei
    Tan, Min
    Yang, Yuhui
    Ning, Hongmei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors
    Montoro, Juan
    Pinana, Jose Luis
    Hernandez-Boluda, Juan C.
    Hernani, Rafael
    Lorenzo, Ignacio
    Perez, Ariadna
    Guerreiro, Manuel
    Balaguer-Rosello, Aitana
    Sanz, Guillermo F.
    Carretero, Carlos
    Albert, Eliseo
    Navarro, David
    Sanz, Miguel A.
    Solano, Carlos
    Sanz, Jaime
    BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2147 - 2159
  • [49] Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT
    Danylesko, Ivetta
    Peczynski, Christophe
    Labopin, Myriam
    Polge, Emmanuelle
    Tischer, Johanna
    Blaise, Didier
    Koc, Yener
    Gulbas, Zafer
    Ciceri, Fabio
    Arat, Mutlu
    Castagna, Luca
    Bruno, Benedetto
    Raiola, Anna Maria
    Botella-Garcia, Carmen
    Savani, Bipin N.
    Piemontese, Simona
    Ruggeri, Annalisa
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2022, 57 (08) : 1260 - 1268
  • [50] Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies
    Ma, Rui
    Huang, Xiao-Jun
    Xu, Lan-Ping
    Liu, Kai-Yan
    Zhang, Xiao-Hui
    Yan, Chen-Hua
    Han, Wei
    Wang, Feng-Rong
    Chen, Yu-Hong
    Chen, Huan
    Chen, Yao
    Wang, Jing-Zhi
    Wang, Yu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (06) : 1210 - 1217